Literature DB >> 27221474

Glycogen synthase kinase-3β antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1.

Na Zhang1, Lu Liu1, Yueying Dou1, Danqing Song1, Hongbin Deng2.   

Abstract

Glycogen synthase kinase-3β (GSK-3β), a multifunctional kinase, is an important regulator of cancer cell survival. Apoptosis signal-regulating kinase 1 (ASK1) is also a key factor for controlling several cellular events including the cell cycle, senescence, and apoptosis, in response to reactive oxygen species (ROS). The role of GSK-3β regulating the activity and protein level of ASK1 in the cancer cells remains largely unexplored. In this study, we showed that GSK-3β inhibits ROS-induced hepatocellular carcinoma cell death by suppressing ASK1. We first found that ectopic expression of GSK-3β suppressed hydrogen peroxide (H2O2)-induced cell death in HepG2 cells and knockdown of endogenous GSK-3β expression exhibited opposite effects. Moreover, GSK-3β expression clearly inhibited H2O2-induced phosphorylation of ASK1 in HepG2 cells, in association with a decrease in ASK1 protein level. Further exploration revealed that GSK-3β induced ubiquitination and proteasome-dependent degradation of ASK1 via inhibition of ubiquitin-specific protease USP9X. Our results thus suggest that GSK-3β is a key factor involved in ASK1 activation and ROS-induced cell death.

Entities:  

Keywords:  ASK1; Glycogen synthase kinase-3β; ROS; Ubiquitination

Mesh:

Substances:

Year:  2016        PMID: 27221474     DOI: 10.1007/s12032-016-0776-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Glycogen synthase kinase-3 and cancer: good cop, bad cop?

Authors:  Satish Patel; Jim Woodgett
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

3.  Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death.

Authors:  Hiroaki Nagai; Takuya Noguchi; Kengo Homma; Kazumi Katagiri; Kohsuke Takeda; Atsushi Matsuzawa; Hidenori Ichijo
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

4.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

5.  S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β.

Authors:  Hongbin Deng; Na Zhang; Yan Wang; Jinjing Chen; Jiajia Shen; Zhen Wang; Rong Xu; Jingpu Zhang; Danqing Song; Diandong Li
Journal:  Exp Cell Res       Date:  2012-09-10       Impact factor: 3.905

Review 6.  Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling.

Authors:  Shigeru Shiizaki; Isao Naguro; Hidenori Ichijo
Journal:  Adv Biol Regul       Date:  2012-09-13

7.  Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1.

Authors:  Go Fujino; Takuya Noguchi; Atsushi Matsuzawa; Shota Yamauchi; Masao Saitoh; Kohsuke Takeda; Hidenori Ichijo
Journal:  Mol Cell Biol       Date:  2007-08-27       Impact factor: 4.272

Review 8.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.

Authors:  Jia Luo
Journal:  Cancer Lett       Date:  2008-07-07       Impact factor: 8.679

9.  The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.

Authors:  Cuiling Ma; Jian Wang; Ying Gao; Tian-Wen Gao; Gang Chen; Kimberly A Bower; Mohammed Odetallah; Min Ding; Zunji Ke; Jia Luo
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

Review 10.  Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?

Authors:  G Garcea; M M Manson; C P Neal; C J Pattenden; C D Sutton; A R Dennison; D P Berry
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

View more
  2 in total

1.  Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.

Authors:  Na Zhang; Xiaojia Liu; Lu Liu; Zhesong Deng; Qingxuan Zeng; Weiqiang Pang; Yang Liu; Danqing Song; Hongbin Deng
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

Review 2.  Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis.

Authors:  Jiaqi Liu; Chi Tim Leung; Luyun Liang; Yuqin Wang; Jian Chen; Keng Po Lai; William Ka Fai Tse
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.